Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrendipine versus nifedipine for mild arterial hypertension
RBR-7ynkx6Phase 3Unknown
- Sponsor
- Libbs Farmacêutica
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of nitrendipine and nifedipine in hypertension (HTN), sponsored by Libbs Farmacêutica. Primary endpoints: Efficacy and Safety. Status: unknown.
02
Drugs
nitrendipinenifedipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on RBR-7ynkx6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7ynkx6.